Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Holista Colltech Limited ( (AU:HCT) ) just unveiled an announcement.
Holista Colltech Limited has received a notice from the Australian Securities and Investments Commission (ASIC) seeking recovery of legal costs amounting to approximately $1.09 million following Federal Court proceedings. The company is currently reviewing the notice and evaluating its options regarding the claim, with further updates to be provided as necessary. This development may impact Holista’s financial obligations and necessitates careful consideration of its legal and operational strategies.
The most recent analyst rating on (AU:HCT) stock is a Hold with a A$0.08 price target. To see the full list of analyst forecasts on Holista Colltech Limited stock, see the AU:HCT Stock Forecast page.
More about Holista Colltech Limited
Holista Colltech Limited is a Perth-based company listed on the Australian Securities Exchange, specializing in health and wellness solutions. It operates across four core business divisions: Dietary Supplements, Healthy Food Ingredients, Ovine Collagen, and Infection Control Solutions. The company is known for its market-leading nutritional supplements, patented low-GI food ingredients, premium ovine collagen, and all-natural sanitizers, reflecting its commitment to combining nature and science for healthier lifestyles.
Average Trading Volume: 72,932
Technical Sentiment Signal: Buy
Current Market Cap: A$32M
For an in-depth examination of HCT stock, go to TipRanks’ Overview page.